Skip to main content

Brooks Laboratories

Healthcare NSE:BROOKS

46.03INR
-6.61 ( -12.56%)

Last update at March 23, 2026, midnight

Day Range

45.2752.64
LowHigh

52 Week Range

68.11 182.06
LowHigh

Fundamentals

  • Previous Close 52.64
  • Market Cap 2213.87M
  • Volume194,432
  • P/E Ratio 16.00
  • EBITDA 88.06M
  • Revenue TTM 927.94M
  • Revenue Per Share TTM 32.67
  • Gross Profit TTM 340.73M
  • Diluted EPS TTM 4.67

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax -97.92M -195.66M -383.78M -238.98M -89.93M
Net income -99.67M -195.92M -209.00M -193.13M -193.76M
Total Revenue 825.57M 794.86M 624.80M 911.85M 770.68M
Gross Profit 139.22M 225.13M 126.02M -79.11M 218.28M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 1236.94M 904.45M 1095.97M 1959.11M 1620.77M
Intangible assets 0.09M 0.73M 1.99M 6.31M 6.88M
Other current assets 34.32M 49.96M 20.71M 0.00M 5.69M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 5.55M 1.02M -25.82M 17.21M 4.88M
Operating Cash 17.62M -96.81M -144.91M -374.41M 44.59M
Free Cash Flow -0.97M -101.20M -149.58M -650.53M -11.55M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
BROOKS
Brooks Laboratories 		-6.61 -12.56% 46.03 2213.87 16.00
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-18.70 -1.05% 1758.40 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-86.50 -1.42% 6013.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-56.30 -1.32% 4213.90 1362716.66 63.48
CIPLA
Cipla Limited 		-34.60 -2.75% 1221.80 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.